Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
about
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)New targets in psoriatic arthritisSyndesmophyte growth in ankylosing spondylitisHigher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated SpondyloarthritisSerum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trialAnkylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-α inhibitorsBone morphogenetic protein 6 polymorphisms are associated with radiographic progression in ankylosing spondylitis.Ankylosis in ankylosing spondylitis: current concepts.Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study.Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysisImpact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis.Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE studyEmerging drugs for the treatment of axial and peripheral spondyloarthritis.Monitoring ankylosing spondylitis: clinically useful markers and prediction of clinical outcomes.Pharmacological therapy of spondyloarthritis.Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials.Recent Advances in Imaging of the Axial Skeleton in Spondyloarthritis for Diagnosis, Assessment of Treatment Effect, and Prognostication.Posttraumatic stress disorder and correlates of disease activity among veterans with ankylosing spondylitis.Mechanism of New Bone Formation in Axial Spondyloarthritis.Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort.Minimal disease activity in axial spondyloarthritis: the need of the hour and a proposal for development.Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis.High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception CRadiographic progression is associated with increased cardiovascular risk in patients with axial spondyloarthritis.Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis.Fat metaplasia on MRI of the sacroiliac joints increases the propensity for disease progression in the spine of patients with spondyloarthritis.Association of ERAP1, IL23R and PTGER4 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis.Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy.TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.Evaluation of periostin and factors associated with new bone formation in ankylosing spondylitis: Periostin may be associated with the Wnt pathway.An update on biomarker discovery and use in axial spondyloarthritis.Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.Effect of mechanical stress on magnetic resonance imaging of the sacroiliac joints: assessment of military recruits by magnetic resonance imaging study.Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial.[Treat-to-target (T2T) recommendation for patients with spondyloarthritis - translation into German].Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis.
P2860
Q24186403-0147F0A2-DE7C-4E30-A473-C160342B639EQ28069592-DFDE7080-9830-40ED-8636-C71D18B29AA2Q28085617-E97135E3-B5FC-4D4B-B288-1504FF6E3F40Q32115630-77B6B329-964A-48C6-9F62-1F47261A046DQ33801148-3B5FC678-9D1D-451E-B991-6045ADF54669Q33825162-FD26FB35-1645-4B21-8FFE-E64117F3DC96Q34046853-F81B3C5E-9911-4914-BB12-836D95508DA9Q34474761-D71FA889-D1B3-4D5C-85BC-3139AB0A07ADQ35449032-B4F4621F-AAD7-41F0-880E-DD8692EB6422Q36215822-C11D90ED-BBC0-465C-92EE-D973129A1DF5Q36235821-6956D425-1164-4267-A5E0-9A7DB012CD80Q37539712-495EBC96-03C8-40BD-BEC7-8F3875E53016Q38313266-0721348A-2BE7-43C2-9F94-A3A87E48BC52Q38517691-51C210B6-6B09-457E-A5DD-A5FEA046F9A6Q38527552-AB8991F5-89F4-472E-A496-69C735978FEFQ38561891-D138B281-B1D1-4961-91B6-C7E049C2FE99Q38561980-8CB2137D-BB51-42E3-813A-F154424DC302Q38608792-A8F56861-29BA-4671-A0CC-B5F605E2B94AQ38655991-636F799A-D408-4F7B-B8E3-DF1709CCE6B9Q38690324-C4A1C823-71D0-4701-9AD7-C2D71322D3F0Q38690333-FD1BFE20-C61E-4774-9B23-95E16839D60FQ39219560-929E33E0-0225-45B1-8E5A-5F77A449913CQ39328132-D196DB41-4894-4F13-BF6C-A867B78266FDQ39328197-2FABA6B4-516D-4735-B52C-ACFF3429028AQ39812956-D34A0695-5BE9-4C93-9FD0-154638D1EDD9Q40324538-80172E66-2799-4287-A792-89EE4CCF41E0Q40505103-F96655F7-9417-4866-9875-909FE3C0F460Q40523969-C859673D-DD2A-4E1E-AA74-55F4FE78B674Q41487881-428DFFD7-CFFC-48B8-BA07-DB9FAA212D9DQ41836518-1AF96903-37E6-4DBD-91CD-7658C615F7B3Q42314322-31FCD34A-F0A0-4BFD-BD6F-FE9621A7E2F6Q43233004-78B80667-8DD8-4556-A225-1EB6F199718FQ47677081-2D4995F6-7551-412F-A87F-A372F9A0FC6CQ47755895-51162492-1F70-4088-B9A9-C3DEC37C0940Q47787817-B1927249-C316-4D85-AD00-3F7D319D82D0Q48112019-82AA1971-CD2C-40CE-B2C3-4EFDF046A6FCQ48533829-4566F076-C8A7-45C4-A438-69420216BBECQ52806531-68D41383-2459-41EE-B467-F07E36EFFDE4Q52849042-7A0E3FFE-1F72-4483-A409-8DF98F975432Q53037194-C369B6FE-E819-43C1-9189-D4332D4891E8
P2860
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Higher disease activity leads ...... al data from the OASIS cohort.
@ast
Higher disease activity leads ...... al data from the OASIS cohort.
@en
type
label
Higher disease activity leads ...... al data from the OASIS cohort.
@ast
Higher disease activity leads ...... al data from the OASIS cohort.
@en
prefLabel
Higher disease activity leads ...... al data from the OASIS cohort.
@ast
Higher disease activity leads ...... al data from the OASIS cohort.
@en
P2860
P50
P1476
Higher disease activity leads ...... al data from the OASIS cohort.
@en
P2093
Filip van den Bosch
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-205178
P407
P50
P577
2014-05-07T00:00:00Z